A Look At Finch Therapeutics' Ch. 11 Plan
Microbiome treatment developer Finch Therapeutics will ask a Delaware bankruptcy judge to approve a Chapter 11 plan that would allow it to sell all assets to a rival company and exit...To view the full article, register now.
Already a subscriber? Click here to view full article